Depression - Articles - Page 14

Oral Contraceptive Users and Depressive Symptoms

October 30, 2020

Kristen Gardner, PharmD. Dr. Gardner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We worry that oral contraceptives impact mood, particularly in adolescents who are prone to depression and other mood disorders. This research review on the Dutch TRAILS (Tracking Adolescents’ Individual Lives Survey) helps balance our decision making so that we avoid either extreme of universally counseling against their use nor dismissing the possible impact of OCs on mood.

Tips on the Doubts about Ketamine/Esketamine

August 19, 2020

Ketamine and esketamine have been shown to provide rapid relief of suicidality, however, many lingering doubts have been raised about these medicines. In a previous article from The Carlat Psychiatry Report, Nolan Williams, M.D., discusses the potential negative consequences of ketamine/esketamine treatment. Here are some of Dr. Williams’s tips:It might...

Navigating the World of Mental Health Apps

August 18, 2020

Many mental health apps can be problematic because "most of the apps that are available are poorly designed and lack research support.” Dr. Torous discusses these apps in an article from The Carlat Psychiatry Report. Here is some of his advice.

EXPERT Q&A

Communicating With Patients About Gender

August 5, 2020

Alex Keuroghlian, MD, MPH

Alex Keuroghlian, MD, MPH

Director, National LGBT Health Education Center at The Fenway Institute; Director, Massachusetts General Hospital Department of Psychiatry Gender Identity Program; Associate Professor, Harvard Medical School Dr. Keuroghlian has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What are the risks for depression and suicide with transgender patients and how can we provide the best care for them? Alex Keuroghlian, MD, MPH, answers that question and more.

When Further Medication Trials Seem Futile

June 10, 2020

Joseph Goldberg, MD

Joseph Goldberg, MD

Dr. Goldberg is a clinical professor of psychiatry at the Mount Sinai School of Medicine and maintains a private practice focused on mood disorders. He has published three psychiatric textbooks and is completing a fourth on psychopharmacology. Dr. Goldberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Joe Goldberg believes we do a disservice by shuffling patients through medication trials that have little chance of working. He shares techniques to engage patients, motivate change, combat demoralization, as well as his top pharmacologic strategies for highly resistant depression.

How Effective is Esketamine [60 Sec Psych]

May 16, 2020

It's been a year since esketamine's (Spravato) debut for treatment resistant depression, and the numbers are in: to treat and to harm. A review of Citrome L, DiBernardo A, Singh J. 144 Esketamine Nasal Spray for Management of Treatment-Resistant Depression: Number Needed to Treat, Number Needed to Harm, Likelihood to...

What Cocaine Tells Us About Depression [60 Sec Psych]

May 13, 2020

Depressed patients who've used cocaine in the past might be more likely to develop bipolar disorder. A review of de Azevedo Cardoso T, Jansen K, Mondin TC, et al. Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: a prospective study. Psychiatry Clin...

Trazodone: The Forgotten Antidepressant

May 7, 2020

Eugene Rubin, MD

Eugene Rubin, MD Private practice, Bingham Farms, MI. Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Trazodone is rarely used as an antidepressant, and that’s a missed opportunity. It lacks the weight gain, sleep disruption, and sexual side effects that so many antidepressants cause. In this article are two important dosing tips that can make it work better.

The Psychopharmacology Algorithm Project

March 30, 2020

David Osser, MD

David Osser, MD

General Editor of the Psychopharmacology Algorithm Project at the Harvard South Shore Psychiatry Residency Training Program and Associate Professor of Psychiatry at Harvard University. Dr. Osser has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Osser set out to develop a psychopharmacology algorithm that actually changes practice. He speaks to us on antidepressants in bipolar, psychoses that don’t need antipsychotics, and his top picks for bipolar mania, bipolar depression, and unipolar depression.

Top Lifestyle Tips for Depression and Bipolar

March 16, 2020

How do you make the most of brief therapy during a medication visit? Chris Aiken, MD, pulls a few of his favorite interventions from his new book, The Depression and Bipolar Workbook.Date Published: 3/16/20Duration: 20 minutes 24 seconds...